E, this time with a clear aim at blocking IL-1-derived inflammation.156 Yet, some evidence suggests a role for IL-1 in the development of these chronic inflammatory diseases. In fact, early IL-1 release is recognized as an important step that initiates inflammation, and IL-1 is thus considered a promising target for the treatment of rheumatologic disease.156,164 Interestingly, RA patients producin


Who Upvoted this Story

Bookmarkingwindow 2019
Latest Comments